Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Feb;38(2):161–165. doi: 10.1136/gut.38.2.161

Gene therapy in gastroenterology.

H S Pandha 1, N R Lemoine 1
PMCID: PMC1383016  PMID: 8801190

Full text

PDF
161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burgess T. L., Fisher E. F., Ross S. L., Bready J. V., Qian Y. X., Bayewitch L. A., Cohen A. M., Herrera C. J., Hu S. S., Kramer T. B. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):4051–4055. doi: 10.1073/pnas.92.9.4051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Caplen N. J., Alton E. W., Middleton P. G., Dorin J. R., Stevenson B. J., Gao X., Durham S. R., Jeffery P. K., Hodson M. E., Coutelle C. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med. 1995 Jan;1(1):39–46. doi: 10.1038/nm0195-39. [DOI] [PubMed] [Google Scholar]
  3. Chowdhury N. R., Wu C. H., Wu G. Y., Yerneni P. C., Bommineni V. R., Chowdhury J. R. Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy. J Biol Chem. 1993 May 25;268(15):11265–11271. [PubMed] [Google Scholar]
  4. Conry R. M., LoBuglio A. F., Kantor J., Schlom J., Loechel F., Moore S. E., Sumerel L. A., Barlow D. L., Abrams S., Curiel D. T. Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res. 1994 Mar 1;54(5):1164–1168. [PubMed] [Google Scholar]
  5. DiMaio J. M., Clary B. M., Via D. F., Coveney E., Pappas T. N., Lyerly H. K. Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo. Surgery. 1994 Aug;116(2):205–213. [PubMed] [Google Scholar]
  6. Dienes H. P., Ramadori G., Falke D., Thoenes W. Electron microscopic observations on primary hepatocyte cultures infected with herpes simplex virus types I and II. Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;46(4):321–332. doi: 10.1007/BF02890320. [DOI] [PubMed] [Google Scholar]
  7. Ferry N., Duplessis O., Houssin D., Danos O., Heard J. M. Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8377–8381. doi: 10.1073/pnas.88.19.8377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gansbacher B., Bannerji R., Daniels B., Zier K., Cronin K., Gilboa E. Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res. 1990 Dec 15;50(24):7820–7825. [PubMed] [Google Scholar]
  9. Hardwick R. H., Shepherd N. A., Moorghen M., Newcomb P. V., Alderson D. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut. 1994 Jun;35(6):764–768. doi: 10.1136/gut.35.6.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hoeg J. M., Starzl T. E., Brewer H. B., Jr Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia. Am J Cardiol. 1987 Mar 1;59(6):705–707. doi: 10.1016/0002-9149(87)91199-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Huber B. E., Austin E. A., Richards C. A., Davis S. T., Good S. S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8302–8306. doi: 10.1073/pnas.91.17.8302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Huber B. E., Richards C. A., Krenitsky T. A. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8039–8043. doi: 10.1073/pnas.88.18.8039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kasahara N., Dozy A. M., Kan Y. W. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science. 1994 Nov 25;266(5189):1373–1376. doi: 10.1126/science.7973726. [DOI] [PubMed] [Google Scholar]
  14. McManaway M. E., Neckers L. M., Loke S. L., al-Nasser A. A., Redner R. L., Shiramizu B. T., Goldschmidts W. L., Huber B. E., Bhatia K., Magrath I. T. Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet. 1990 Apr 7;335(8693):808–811. doi: 10.1016/0140-6736(90)90934-w. [DOI] [PubMed] [Google Scholar]
  15. Miller A. D. Human gene therapy comes of age. Nature. 1992 Jun 11;357(6378):455–460. doi: 10.1038/357455a0. [DOI] [PubMed] [Google Scholar]
  16. Miyanohara A., Elam R. L., Witztum J. L., Friedmann T. Long-term transgene expression from genetically modified hepatocytes grafted to the rat liver. New Biol. 1992 Mar;4(3):261–267. [PubMed] [Google Scholar]
  17. Offensperger W. B., Offensperger S., Walter E., Teubner K., Igloi G., Blum H. E., Gerok W. In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO J. 1993 Mar;12(3):1257–1262. doi: 10.1002/j.1460-2075.1993.tb05767.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Park R. W., Grand R. J. Gastrointestinal manifestations of cystic fibrosis: a review. Gastroenterology. 1981 Dec;81(6):1143–1161. [PubMed] [Google Scholar]
  19. Rosenberg S. A., Aebersold P., Cornetta K., Kasid A., Morgan R. A., Moen R., Karson E. M., Lotze M. T., Yang J. C., Topalian S. L. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med. 1990 Aug 30;323(9):570–578. doi: 10.1056/NEJM199008303230904. [DOI] [PubMed] [Google Scholar]
  20. Roth J. A., Mukhopadhyay T., Zhang W. W., Fujiwara T., Georges R. Gene replacement strategies for the prevention and therapy of cancer. Eur J Cancer. 1994;30A(13):2032–2037. doi: 10.1016/0959-8049(94)00398-o. [DOI] [PubMed] [Google Scholar]
  21. Savransky E., Hytiroglou P., Harpaz N., Thung S. N., Johnson E. M. Correcting the PiZ defect in the alpha 1-antitrypsin gene of human cells by targeted homologous recombination. Lab Invest. 1994 May;70(5):676–683. [PubMed] [Google Scholar]
  22. Shirasawa S., Furuse M., Yokoyama N., Sasazuki T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science. 1993 Apr 2;260(5104):85–88. doi: 10.1126/science.8465203. [DOI] [PubMed] [Google Scholar]
  23. Skipper J., Stauss H. J. Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras protein. J Exp Med. 1993 May 1;177(5):1493–1498. doi: 10.1084/jem.177.5.1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Symmans P. J., Linehan J. M., Brito M. J., Filipe M. I. p53 expression in Barrett's oesophagus, dysplasia, and adenocarcinoma using antibody DO-7. J Pathol. 1994 Jul;173(3):221–226. doi: 10.1002/path.1711730304. [DOI] [PubMed] [Google Scholar]
  25. Townsend S. E., Allison J. P. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science. 1993 Jan 15;259(5093):368–370. doi: 10.1126/science.7678351. [DOI] [PubMed] [Google Scholar]
  26. Westbrook C. A., Chmura S. J., Arenas R. B., Kim S. Y., Otto G. Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery. Hum Mol Genet. 1994 Nov;3(11):2005–2010. doi: 10.1093/hmg/3.11.2005. [DOI] [PubMed] [Google Scholar]
  27. Wilson J. M., Chowdhury J. R. Prospects for gene therapy of familial hypercholesterolemia. Mol Biol Med. 1990 Jun;7(3):223–232. [PubMed] [Google Scholar]
  28. Wilson J. M., Johnston D. E., Jefferson D. M., Mulligan R. C. Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4421–4425. doi: 10.1073/pnas.85.12.4421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wu G. Y., Wu C. H. Delivery systems for gene therapy. Biotherapy. 1991;3(1):87–95. doi: 10.1007/BF02175102. [DOI] [PubMed] [Google Scholar]
  30. Wu G. Y., Wu C. H., Rubin M. I. Acetaminophen hepatotoxicity and targeted rescue: a model for specific chemotherapy of hepatocellular carcinoma. Hepatology. 1985 Sep-Oct;5(5):709–713. doi: 10.1002/hep.1840050502. [DOI] [PubMed] [Google Scholar]
  31. Wu G. Y., Wu C. H. Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. J Biol Chem. 1992 Jun 25;267(18):12436–12439. [PubMed] [Google Scholar]
  32. Yang Y., Raper S. E., Cohn J. A., Engelhardt J. F., Wilson J. M. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4601–4605. doi: 10.1073/pnas.90.10.4601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yonish-Rouach E., Grunwald D., Wilder S., Kimchi A., May E., Lawrence J. J., May P., Oren M. p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol. 1993 Mar;13(3):1415–1423. doi: 10.1128/mcb.13.3.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zhou L., Dey C. R., Wert S. E., DuVall M. D., Frizzell R. A., Whitsett J. A. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science. 1994 Dec 9;266(5191):1705–1708. doi: 10.1126/science.7527588. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES